Valence — Autonomous BD for Life Sciences

Your pipeline,
filled by AI.
Zero headcount added.

Valence autonomously identifies, engages, and converts life sciences prospects — so your commercial team focuses on closing, not hunting.

4–12

Qualified meetings / month

24/7

Autonomous prospecting

€0

Full-time BD hire cost

No long-term contract. Results within 30 days.

How Valence Works

Every step of the BD cycle, handled without you.

01 / Prospect Discovery

Valence finds your next 200 prospects while you sleep.

Using structured company databases, regulatory filings, LinkedIn, and conference data, Valence builds a continuously updated list of CROs, CDMOs, biotechs, and pharma services firms that match your ideal customer profile — scored and ranked by fit, size, and buying signal.

Prospect Queue — Live 247 active

Novatek Pharma Services

CDMO · Ireland

94

Hiring BD Director

Bioreliance EU GmbH

CRO · Germany

88

Phase II expansion

Aptuit (Evotec)

CRO · Italy

82

New oncology unit

PMRS Clinical

CRO · UK

79

Conference: DIA 2025

Draft Outreach — Bioreliance EU
Subject: Partnering on Phase II bioanalytical capacity — a fit?

Dear Dr. Müller,

I noticed Bioreliance is expanding your oncology unit in Munich — congratulations on the Phase II win. We work with several European CROs at this stage of growth to accelerate their commercial pipeline without adding headcount...

GDPR-COMPLIANT AUTO-FOLLOW-UP: 3 STEPS
02 / Personalised Outreach

Every message is written for the individual, not the segment.

Valence drafts personalised outreach using public intelligence — company news, personnel changes, conference presentations — so your messages land with context. Three-step follow-up sequences run automatically, with replies routed directly to your inbox.

03 / Meetings & Reporting

Meetings confirmed. Reports delivered. You just show up.

When a prospect responds positively, Valence handles scheduling, sends calendar invites, and briefs you with a contact summary before the call. Weekly reports show pipeline velocity, response rates, and the commercial opportunities moving through your funnel.

Weekly Pipeline Report W/E 25 July 2025

6

Meetings booked

34%

Open rate

€240k

Pipeline added

Aptuit (Evotec) Meeting: Tue 29 Jul 10:00
Novatek Pharma Meeting: Thu 31 Jul 14:30
PMRS Clinical Follow-up sent — awaiting reply

4–12

Qualified meetings per month

Per client engagement, on average

98%

Of the process is automated

You review. Valence executes.

30d

To first qualified meetings

Onboarding to pipeline in one month

€0

Internal BD headcount required

No hire. No training. No management.

Why Valence

The BD model built for life sciences — not adapted from it.

Capability Valence Traditional Agency
24/7 prospect identification
Personalised outreach at scale
GDPR-compliant automation
Life sciences ICP expertise
Weekly performance reporting
No long-term contract required
Scales without headcount
Results within 30 days

Built for 6–18 month sales cycles

Valence understands that life sciences deals move slowly. Persistent, structured follow-up keeps your prospects warm over months — not weeks.

Life sciences ICP precision

We target CROs, CDMOs, biotech, pharma services, and MedTech — not generic B2B. Sector fluency means your messages land with credibility.

Regulatory-aware outreach

All campaigns are structured for GDPR compliance. No spray-and-pray. Targeted, documented, defensible.

You own the relationships

Valence fills your calendar — your commercial team runs the meeting. No middleman, no lock-in, no dependency.

Pricing

Fixed monthly retainer.
No hiring costs. No surprises.

All plans run month-to-month. Cancel anytime. Pricing is in EUR and invoiced monthly.

Launch

€2,500/mo

For life sciences firms testing AI-driven BD for the first time.

  • Up to 150 targeted prospects/month
  • Personalised email outreach
  • 3-step automated follow-up
  • CRM updates & tagging
  • Weekly performance report
  • 1 target vertical
Get started
Recommended

Scale

€4,500/mo

For commercial teams that need a reliable, full-cycle pipeline engine.

  • Up to 400 targeted prospects/month
  • Personalised email + LinkedIn outreach
  • 5-step automated follow-up
  • CRM integration (HubSpot/Salesforce)
  • Meeting scheduling & briefing notes
  • 2 target verticals or geographies
  • Monthly strategy review call
Book a discovery call

Enterprise

Custom

For larger CROs and CDMOs with complex, multi-region BD requirements.

  • Unlimited prospect volume
  • Multi-channel outreach strategy
  • Dedicated account management
  • Custom CRM architecture
  • Partnership & distributor targeting
  • Multiple verticals & geographies
  • Bespoke reporting & KPI dashboards
Enquire now

All pricing in EUR excl. VAT. Month-to-month — no minimum commitment. Invoiced on the 1st of each month.

FAQ

Common questions about Valence.

Anything not covered here? Send your question to hello@valence.ai

How quickly does Valence start generating results?

Onboarding takes 3–5 business days to configure your ICP, outreach templates, and CRM integration. You should see your first qualified meetings booked within 30 days of going live.

What types of life sciences companies does Valence target?

Valence is purpose-built for CROs, CDMOs, biotech firms, pharma service providers, MedTech companies, and specialist laboratory businesses. We do not work outside life sciences.

Is the outreach GDPR-compliant?

Yes. All campaigns are structured for GDPR compliance under the legitimate interest basis applicable to B2B commercial communications in the EU and Ireland. We maintain documented records of every outreach campaign and prospect source.

What do I need to provide to get started?

Your ideal customer profile, a brief on your services or capabilities, and access to your CRM or calendar for meeting booking. We handle everything else — prospect research, copywriting, scheduling, and reporting.

Do I need to be involved in day-to-day operations?

No. Valence runs autonomously. You receive a weekly report, are notified when a qualified prospect replies positively, and are briefed before confirmed meetings. Your involvement is reviewing the weekly summary and showing up to calls.

Does Valence replace my existing BD team?

Valence is designed for companies without a dedicated BD hire, or where the commercial team is focused on closing rather than hunting. If you have an existing BD team, Valence augments their pipeline rather than replacing them.

What is the minimum commitment?

There is no minimum commitment. All plans run month-to-month. You can cancel with 30 days notice. We are confident in results, so we do not rely on contracts to retain clients.

Which geographies does Valence cover?

Our primary focus is Ireland, the UK, and continental Europe. We can extend to North America and Asia-Pacific for Enterprise clients with specific geographic requirements.

Start building your pipeline

Your commercial team should be closing deals,
not hunting for them.

Book a 30-minute discovery call. We will map Valence to your ICP, show you what a typical month of pipeline generation looks like, and confirm whether we are a fit — before you commit to anything.

"Valence booked us 7 qualified meetings in the first 6 weeks — with zero time spent by our team on prospecting."

Head of BD, Irish CRO

Book a discovery call

30 minutes. No pitch deck. Just a clear conversation.

We map Valence to your exact ICP
You see a real prospect database sample
We confirm fit before you commit
Request my discovery call

Response within 1 business day. No obligation.

30d

To first results

€0

Setup fee

0

Hires required